• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, June 25, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

When medicine is not enough for schizophrenia and psychosis

Bioengineer by Bioengineer
June 30, 2022
in Chemistry
Reading Time: 2 mins read
0
Webinar Moderator and President and CEO of the Brain & Behavior Research Foundation
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “When Medicine is Not Enough for Schizophrenia and Psychosis” on Tuesday, July 12, 2022, at 2:00 pm EDT. The presenter will be Dawn I. Velligan, Ph.D., Director of the Division of Community Recovery, Research and Training and Henry B. Dielmann Chair, Department of Psychiatry at the University of Texas Health Science Center in San Antonio. Dr. Velligan was a recipient of a 2016 Distinguished Investigator Grant and 2002 Independent Investigator Grant. Register today at BBRFoundation.org

Webinar Moderator and President and CEO of the Brain & Behavior Research Foundation

Credit: Brain & Behavior Research Foundation

The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “When Medicine is Not Enough for Schizophrenia and Psychosis” on Tuesday, July 12, 2022, at 2:00 pm EDT. The presenter will be Dawn I. Velligan, Ph.D., Director of the Division of Community Recovery, Research and Training and Henry B. Dielmann Chair, Department of Psychiatry at the University of Texas Health Science Center in San Antonio. Dr. Velligan was a recipient of a 2016 Distinguished Investigator Grant and 2002 Independent Investigator Grant. Register today at BBRFoundation.org

Many individuals experience continued symptoms for schizophrenia and psychosis despite the best medication treatments available. What are some of the therapy approaches that can help when medicine is not enough? How do these approaches work? Jeffrey Borenstein, M.D., President and CEO of the Brain & Behavior Research Foundation and Host and Executive Producer of the public television series “Healthy Minds,” will be the moderator.

This webinar is part of a series of free monthly “Meet the Scientist” webinars on the latest developments in psychiatry offered by the Brain & Behavior Research Foundation.

About Brain & Behavior Research Foundation 

The Brain & Behavior Research Foundation awards research grants to develop improved treatments, cures, and methods of prevention for mental illness. These illnesses include addiction, ADHD, anxiety, autism, bipolar disorder, borderline personality disorder, depression, eating disorders, OCD, PTSD, and schizophrenia, as well as research on suicide prevention. Since 1987, the Foundation has awarded more than $430 million to fund more than 5,100 leading scientists around the world, which has led to over $4 billion in additional funding for these scientists. 100% of every dollar donated for research is invested in research. BBRF operating expenses are covered by separate foundation grants. BBRF is the producer of the Emmy® nominated public television series Healthy Minds with Dr. Jeffrey Borenstein, which aims to remove the stigma of mental illness and demonstrate that with help, there is hope.



Share12Tweet8Share2ShareShareShare2

Related Posts

AI and Physics Collaborate to Design Advanced Hydrogen Storage Materials

June 25, 2026

International Team Including Dresden Scientists Develops Novel Designer Proteins for Advanced Study of Living Tissue

June 25, 2026

New Study Uncovers Key Factors Driving Water Chemistry in Nanoscale Environments

June 25, 2026

Plasma Technology Extends Catalyst Lifespan in Hydrogen Production

June 24, 2026

POPULAR NEWS

  • Saying Goodbye to PGY-6: Pediatric Fellowship Realities

    103 shares
    Share 41 Tweet 26
  • Multi-Hospital Study Reveals Long Covid Burden Is Twice as High as Current Estimates

    92 shares
    Share 36 Tweet 23
  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tracking Lanthanide-Labeled Microplastics in Plants

POSTECH Researchers Slash Cost of Reconstituted Cell-Free Systems by 95%

AI and Physics Collaborate to Design Advanced Hydrogen Storage Materials

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.